​

Edgewise Therapeutics (EWTX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Edgewise Therapeutics Revenue Highlights

00

Edgewise Therapeutics Revenue by Period

Edgewise Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Edgewise Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Edgewise Therapeutics Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$2.12M100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$2.25M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Edgewise Therapeutics generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Edgewise Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
GLPGGalapagos$239.70M$62.43M
OCULOcular Therapeutix$63.46M$14.54M
QUREuniQure$27.12M$3.70M
JANXJanux Therapeutics$10.59M$10.00M
NUVBNuvation Bio$7.87M$13.12M
MESOMesoblast$7.50M$1.69M
CLDXCelldex Therapeutics$7.02M-
GPCRStructure Therapeutics--
VRDNViridian Therapeutics-$70.57M
EWTXEdgewise Therapeutics--
VERAVera Therapeutics--

EWTX Revenue FAQ

What is Edgewise Therapeutics’s yearly revenue?

Edgewise Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. EWTX's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Edgewise Therapeutics’s quarterly revenue?

Edgewise Therapeutics's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). EWTX's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Edgewise Therapeutics’s revenue growth rate?

Edgewise Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.